Key result
Among 5,897 older Medicare beneficiaries with troponin-only-positive AMI, traditional sex and racial disparities in evidence-based medication prescriptions and outcomes were resolved.
Why the study?
Do sex and racial disparities persist in the guideline-based management and outcomes of older patients with troponin-only-positive acute myocardial infarction?
Observational (n=5,897)
Yes
Do sex and racial disparities persist in the guideline-based management and outcomes of older patients with troponin-only-positive acute myocardial infarction?
In older Medicare beneficiaries with troponin-only-positive AMI, traditional sex and racial disparities in evidence-based medication prescription and clinical outcomes were not observed.
Disparities resolved in this older Medicare cohort; leaves open generalizability and need for prospective confirmation in broader AMI populations.
Multiple studies have shown sex and racial differences in the management and outcomes of ischemic heart disease, but whether these sex and racial disparities persist in patients with troponin‐only‐positive acute myocardial infarction (AMI) is unknown. The authors evaluated a nationwide sample of eligible Medicare beneficiaries, 65 years or older, who were hospitalized (N=71,120) with a primary discharge diagnosis of AMI. Analysis was restricted to patients with troponin‐only‐positive AMI (n=5897) and was substratified into 4 groups: white men, white women, nonwhite men, and nonwhite women. The authors found that the traditional sex and racial disparities in the evidence‐based medication prescriptions for ischemic heart diseases resolved in this cohort of older patients. Similarly, in settings of equal care, sex and race seem to have no impact on the outcomes for older patients with troponin‐only‐positive AMI.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2007) conducted an observational in Troponin-only-positive acute myocardial infarction (n=5,897). Sex and race was evaluated on Evidence-based medication prescriptions and outcomes. Among 5,897 older Medicare beneficiaries with troponin-only-positive AMI, traditional sex and racial disparities in evidence-based medication prescriptions and outcomes were resolved.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: